 |
|
| |
Allergan has been a leader in the field of Dermatology for the past 7 years. With its beginnings in novel retinoid research with Tazorac® and most recently establishing Global leadership in botulinum toxin research and development with BOTOX® / BOTOX Cosmetic®, Allegan has contributed to further the dynamic field of Dermatology. In Cosmetic Dermatology, Allergan has established itself as market leaders in botulinum toxin technology and business practices. The creation of cutting edge programs and support roles for both science and business practices help Dermatologists attain their goals of being the key resource for patients seeking expert cosmetic advice. In addition, Allergan is the market leaders in the investment of public and professional education and awareness about the benefits of cosmetic treatments. In medical Dermatology, Allergan is the industry leader in furthering the education and awareness to both public and medical professionals about Hyperhidrosis. In 2005, Allergan partnered with the Canadian Dermatology Association (CDA) to declare July Hyperhidrosis Awareness month which was a very successful media event. Allergan Skin Care is a proud supporter of the Canadian Dermatology Foundation.
Click here to close this window
|
